NLM Logo

Octreotide MeSH Descriptor Data 2023


MeSH Heading
Octreotide
Tree Number(s)
D04.345.566.650
D12.644.641.650
Unique ID
D015282
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015282
Scope Note
A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
Entry Term(s)
Compound 201-995
Octreotide Acetate
Octreotide Acetate Salt
SAN 201-995
SM 201-995
SMS 201-995
Sandostatin
Sandostatine
Sandoz 201-995
Pharm Action
Gastrointestinal Agents
Antineoplastic Agents, Hormonal
Registry Number
RWM8CCW8GP
Related Numbers
75R0U2568I
83150-76-9
CAS Type 1 Name
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-
Previous Indexing
Antineoplastic Agents (1982-1988)
Somatostatin/analogs & derivatives (1982-1988)
Public MeSH Note
89
History Note
89
Date Established
1989/01/01
Date of Entry
1988/05/23
Revision Date
2013/07/08
Octreotide Preferred
SMS 201-995 Narrower
Octreotide Acetate Narrower
Sandostatine Narrower
page delivered in 0.156s